CALC is currently covered by 2 analysts
CalciMedica's activity chart (see below) currently has 20 price targets and 23 ratings on display. The stock rating distribution of CALC is 100% BUY.
Highest price target for CALC is $5, Lowest price target is $3.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 04-Mar-2026. First documented stock forecast 19-Jun-2023.
Currently out of the existing stock ratings of CALC, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Nov-2023
$100
8 months 16 days ago
(04-Mar-2026)
0/6 (0%)
$77.35 (341.50%)
Buy Since 28-Jan-2024
9 months 23 days ago
(28-Jan-2026)
0/8 (0%)
$63.15 (374.78%)
Buy Since 26-Jun-2024
$75
$110
2 years 4 months 25 days ago
(26-Jun-2024)
0/2 (0%)
$59.25 (376.19%)
Buy Since 19-Jun-2023
$85
$85
3 years 4 months 14 days ago
(06-Jul-2023)
0/2 (0%)
$65.7 (340.41%)
Which analyst most recently updated their price target on CALC (CalciMedica)?
Which analyst has the lowest performance score on CALC (CalciMedica) with a proven track record?
Which analyst has the most public recommendations on CALC (CalciMedica)?
Which analyst is the currently most bullish on CALC (CalciMedica)?
Which analyst is the currently most reserved on CALC (CalciMedica)?